No spam. Unsubscribe anytime.
HPLC Purity Analysis
Cagrilintide
CAS: 1415456-99-3
energy-balance research and metabolic signaling research (standalone and combination) · Amylin receptor pharmacology · appetite-signaling research neuroscience
Cagrilintide is a long-acting amylin receptor agonist that mimics the satiety signaling effects of the pancreatic hormone amylin.
- energy-balance research and metabolic signaling research (standalone and combination)
- Amylin receptor pharmacology
- appetite-signaling research neuroscience
- CagriSema combination therapy trials
This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Frequently Bought Together
Bacteriostatic Water
Required for reconstitution
Semaglutide
GLP-1 / Weight Management
No spam. Unsubscribe anytime.
HPLC Purity Analysis
Specifications
How Cagrilintide Works
Cagrilintide is a long-acting amylin receptor agonist that mimics the satiety signaling effects of the pancreatic hormone amylin. It activates amylin receptors (AMY1 and AMY3) and calcitonin receptors in the area postrema and nucleus tractus solitarius of the brainstem, reducing appetite and food intake. The C20 fatty acid modification enables albumin binding for extended duration of action. It is being developed in combination with semaglutide (CagriSema) for enhanced metabolic research.
Research Applications
Pricing
| Size | Per Vial | 10-Pack | Savings |
|---|---|---|---|
5mgSale | $86.95$100.00 | $869.50 | 13% off |
10mgBest Value | $160.00 | $1600.00 | — |
10-pack pricing shown. Volume discounts for 50+ vials — contact us.
Certificate of Analysis
This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every order.
Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Related Peptides
Up to 50% OffSemaglutide
Clinically studied for steady weight reduction — once weekly
Up to 60% OffTirzepatide
The most studied dual-agonist for weight reduction
Up to 78% OffRetatrutide
Triple-receptor agonist studied for enhanced metabolic activity
Up to 38% OffLiraglutide
Daily GLP-1 studied for steady appetite regulation